Conjugated linoleic acid synergizes with the CYP1B1 inhibitor 2,31,4,5'-tetramethoxystilbene in suppressing breast cancer cell growth.

被引：0
|
作者：
Kirma, N. B. [1 ]
Nair, H. B. [1 ]
Liu, Y-G [1 ]
Tekmal, R. R. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [21] Human CYP1B1 prevents TRAIL-DR4-mediated cancer cell apoptosis through downregulation of miR-375
    Kwon, Yeo-Jung
    Ye, Dong-Jin
    Baek, Huoung-Seok
    Shin, Sangyun
    Kwon, Tae-Uk
    Cho, Eunah
    Ahn, Hong-Gyu
    Chun, Youngjin
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles
    Spatzenegger, M
    Wang, QM
    He, YQ
    Wester, MR
    Johnson, EF
    Halpert, JR
    MOLECULAR PHARMACOLOGY, 2001, 59 (03) : 475 - 484
  • [23] Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2 and prostate cancer risk and aggressiveness in Bulgarian patients
    Kachakova, Darina
    Mitkova, Atanaska
    Popov, Elenko
    Beltcheva, Olga
    Vlahova, Alexandrina
    Dikov, Tihomir
    Christova, Svetlana
    Mitev, Vanio
    Slavov, Chavdar
    Kaneva, Radka
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (03) : 626 - 640
  • [24] Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5 and CYP2B1 by phenylimidazoles.
    Spatzenegger, M
    Wang, Q
    He, YQ
    Halpert, JR
    FASEB JOURNAL, 2000, 14 (08): : A1337 - A1337
  • [25] MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1
    Mao, Ming
    Wu, Zhouqing
    Chen, Jiakuan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (02) : 649 - 655
  • [26] Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression
    Mohamed, Hossam T.
    Gadalla, Ramy
    El-Husseiny, Noura
    Hassan, Hebatallah
    Wang, Zhongyan
    Ibrahim, Sherif A.
    El-Shinawi, Mohamed
    Sherr, David H.
    Mohamed, Mona M.
    JOURNAL OF ADVANCED RESEARCH, 2019, 16 : 75 - 86
  • [27] Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1
    Lim, DY
    Tyner, AL
    Park, JB
    Lee, JY
    Choi, YH
    Park, JHY
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (01) : 107 - 113
  • [28] Combined Effect of CYP1B1 Codon 432 Polymorphism and N-Acetyltransferase 2 Slow Acetylator Phenotypes in Relation to Breast Cancer in the Turkish Population
    Ozbek, Yasemin K.
    Ozturk, Tulin
    Tuzuner, Bora M.
    Calay, Zerrin
    Ilvan, Sennur
    Seyhan, Fatih M.
    Kisakesen, Halil I.
    Ozturk, Oguz
    Isbir, Turgay
    ANTICANCER RESEARCH, 2010, 30 (07) : 2885 - 2889
  • [29] Long-term exposure of 4-hydroxyestradiol induces the cancer cell characteristics via upregulating CYP1B1 in MCF-10A cells
    Wu Lanxiang
    Wang Bin
    Xu Ge
    Huang Yutang
    Wen Chunjie
    Zhou Honghao
    TOXICOLOGY MECHANISMS AND METHODS, 2019, 29 (09) : 686 - 692
  • [30] Combinatory effect of EZH2 inhibitor and dopamine D1 receptor agonist enhance inhibition of triple negative breast cancer cell growth.
    Kushwaha, Prem Prakash
    Verma, Shiv
    Sarathy, Gautham
    Kumar, Anmol
    Gupta, Sanjay
    Ramaswamy, Bhuvaneswari
    Majumder, Sarmila
    Shankar, Eswar
    CANCER RESEARCH, 2022, 82 (12)
12345